Literature DB >> 10083167

Is a fatty liver dangerous for transplantation?

R Canelo1, F Braun, B Sattler, B Klinge, T Lorf, G Ramadori, B Ringe.   

Abstract

Mesh：

Year:  1999        PMID： 10083167     DOI： 10.1016/s0041-1345(98)01685-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  Glial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers.

Authors:  Sahar Taba Taba Vakili; Roshni Kailar; Khalidur Rahman; Behtash Ghazi Nezami; Simon Musyoka Mwangi; Frank A Anania; Shanthi Srinivasan
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

2.  Is there still a need for living-related liver transplantation in children?

Authors:  D C Broering; L Mueller; R Ganschow; J S Kim; E G Achilles; H Schäfer; M Gundlach; L Fischer; M Sterneck; C Hillert; K Helmke; J R Izbicki; M Burdelski; X Rogiers
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

3.  Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

Authors:  Jan P Deroose; Geert Kazemier; Pieter Zondervan; Jan N M Ijzermans; Herold J Metselaar; Ian P J Alwayn
Journal:  HPB (Oxford)       Date:  2011-04-07       Impact factor: 3.647

Review 4.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

5.  Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Authors:  Araní Casillas-Ramírez; Amine Zaouali; Susagna Padrissa-Altés; Ismail Ben Mosbah; Anna Pertosa; Izabel Alfany-Fernández; Maria Bintanel-Morcillo; Carme Xaus; Antoni Rimola; Juan Rodés; Joan Roselló-Catafau; Carmen Peralta
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.

Authors:  Deepak Nagrath; Hongzhi Xu; Yoko Tanimura; Rongjun Zuo; François Berthiaume; Marco Avila; Rubin Yarmush; Martin L Yarmush
Journal:  Metab Eng       Date:  2009-06-07       Impact factor: 9.783

7.  Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.

Authors:  D Degli Esposti; M Sebagh; P Pham; M Reffas; C Poüs; C Brenner; D Azoulay; A Lemoine
Journal:  Cell Death Dis       Date:  2011-01-13       Impact factor: 8.469

Review 8.  Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

Authors:  Chenjiao Wu; Chao Lu; Chengfu Xu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Impact of steatosis on perioperative outcome following hepatic resection.

Authors:  David A Kooby; Yuman Fong; Arief Suriawinata; Mithat Gonen; Peter J Allen; David S Klimstra; Ronald P DeMatteo; Michael D'Angelica; Leslie H Blumgart; William R Jarnagin
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

10.  Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.

Authors:  Akitoshi Matsuda; Naohisa Kuriyama; Hiroyuki Kato; Akihiro Tanemura; Yasuhiro Murata; Yoshinori Azumi; Masashi Kishiwada; Shugo Mizuno; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.